|

Orforglipron Clinical Trials

5 actively recruiting trials across 2 locations

Also known as: (LY3502970), LY3502970

Sun City West, Arizona3 trials

A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes

Clinical Research Institute of Arizona (CRI) - Sun City West

Phase 3
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes

Clinical Research Institute of Arizona (CRI) - Sun City West

Phase 3
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity

Clinical Research Institute of Arizona (CRI) - Sun City West

Phase 3

Other1 trial

A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Phase 3

Phoenix, Arizona1 trial

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee

Arizona Research Center

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.